Gynecologic Cancer
Conference Coverage
Metastatic cancer linked to worse outcomes of COVID-19
Opinion
What is the significance of isolated tumor cells in endometrial cancer?
More research needs to be performed to definitively address the clinical significance of ITCs.
Feature
ASCO panel outlines cancer care challenges during COVID-19 pandemic
Feature
Will coronavirus restrictions lead to more advanced cancers?
From the Journals
European cancer centers restructure care in the era of COVID-19
Guidelines
ESMO offers ‘European perspective’ on treating gynecologic cancers during the pandemic
From the Journals
Want to keep cancer patients and providers safe during the pandemic? Here’s how
Prescreening, telemedicine, and limited interventions top the list of best practices for patients, while PPE, telecommuting, and wellness/stress...
Feature
Cancer patients report delays in treatment because of COVID-19
Half of survey respondents in active treatment reported changes, delays, or disruptions to care.
Conference Coverage
Update confirms survival benefit with trastuzumab in uterine serous carcinoma
Longer follow-up has revealed improvements in progression-free and overall survival when trastuzumab is added to carboplatin and paclitaxel.
From the Journals
Cancer care ‘transformed in space of a month’ because of pandemic
Changes brought about by COVID-19 may endure after the pandemic is over.
Conference Coverage
Survey reveals gender pay discrepancies among gyn-oncs